The putative cancer-causing CDKs and cyclins driven by somatic mutations were predicted by integration of five complementary methods to identify the genes with mutations that have significant signs of positive selection during tumor evolution.


Summary of mutation frequency of the CDKs/cyclins in each cancer type

List of the putative cancer-causing CDKs/cyclins driven by somatic mutations in each cancer type

Summary of the M-score of the CDKs/cyclins in each cancer type

Pan-cancer level overall M-score of the CDKs/cyclins


Contact us | | Terms & Conditions.
Copyright © 2015 University of Pennsylvania. All Rights Reserved.